Dissertation > Excellent graduate degree dissertation topics show

Express and Clinical Significance of Nidogen-1 and Nidogen-2 in Ovarian Epithelial Tumors

Author: ChenYan
Tutor: JinPing
School: Lanzhou University
Course: Obstetrics and Gynaecology
Keywords: Nidogen-2 CA125 ovarian serous tumors tumor markers nidogen-1 nidogen-2 ovarian neoplasms Immunohistochemistry
CLC: R737.31
Type: Master's thesis
Year: 2011
Downloads: 24
Quote: 0
Read: Download Dissertation

Abstract


Objective:To research the expression of the nidogen-2 as a new ovarian serous carcinoma biomarker in serum of patients, and to explore the value of the combination of nidogen-2 and carbohydrateantigenl25 (CA125) in ovarian serous tumor diagnosis. Methods:Nidogen-2 was measured by immunoassay in serum of 40 women with ovarian serous carcinoma.22 women with ovarian serous cystadenoma and 15 ovarian healthy women, meanwhile, monitoring the level of serum CA125 by chemiluminescent immunoassay (CLIA) of patients. Results:1. CA125 concentration in serum of early and advanced ovarian serous carcinoma patients was elevated (P<0.05).And its significantly higher than those of ovarian serous cystadenoma patients and normal (P<0.05); advanced ovarian serous carcinoma was higher than that of early ovarian serous carcinoma ((median,733.20K.U/L;166.80KU/L;P<0.05). However, serum nidogen-2 concentration between normal and varian serous cystadenoma patients was not different. Receive operating characteristic curve(ROC curve) analysis conclude that nidogen-2 could significantly supplement CA125 as an additional ovarian serous carcinoma biomarker.2.Nidogen-2 concentration in serum of early and advanced ovarian serous carcinoma patients was elevated (median.35.57μg/L and 57.23μg/L).and its significantly higher than those of ovarian serous cystadenoma patients and normal (median,15.72μg/L,15.27μg/L; P<0.05); advanced ovarian serous carcinoma was higher than that of early ovarian serous carcinoma (P<0.05). However, serum nidogen-2 concentration between normal and varian serous cystadenoma patients was not different. Receive operating characteristic curve(ROC curve) analysis conclude that nidogen-2 could significantly supplement CA125 as an additional ovarian serous carcinoma biomarker. Conclusion:Nidogen-2 is a new biomarker for ovarian serous carcinoma. Objective To research the expression of the nidogens (nidogen-1 and nidogen-2) in ovarian epithelial tumors, in order to explore the correlation with invasion of the basement membrane in ovarian cancer. Methods Using immunohistochemical method, we examined the nidogen-1 and nidogen-2 expression in 21 malignant epithelial ovarian tissues,11 borderline ovarian tissues and 19 epithelial ovarian benign tissues, and to compare its expression. Results No expression of nidogen-1 and nidogen-2 was found out in ovarian cancer. Nidogen-1 expression rates were 73.68% and 63.64% in epithelial ovarian benign tumors and borderline ovarian tumors, respectively. There were significant differences between three groups (P<0.01). Nidogen-2 expression rates were 68.42% and 54.55% in epithelial ovarian benign tumors and borderline ovarian tumors, respectively. There were significant differences between three groups (P<0.01). Conclusion The expression of nidogen-1 and nidogen-2 correlates closely with invasion of the basement membrane in ovarian cancer.

Related Dissertations

  1. Roles of MMP-7 and Lysozyme in the Pathogenesis of Ulcerative Colitis Induced by DSS in Balb/c Mice,S858.91
  2. The Study of Kisspeptin/GPR54 System on the Reproductive Regulation in the Hen’s Hypothalamus-Pituitary-Ovary Axis,S831
  3. Study on the Digestive Tube During the Embryonic Stage of Gushi Chicken,S831
  4. A Comparative Study of prawns, crabs, Spiroplasma disease immunohistochemistry and pathology,S945
  5. Expression of WW Domain Containing Oxidoreductase Gene in Cholangiocarcinoma and Its Effect on the Biological Behavior of Cancer Cell Line QBC939,R735.8
  6. Expressions of PRL-3 and p27 in Gastric Carcinoma and Their Clinical Significance,R735.2
  7. Expression of hnRNP A2/B1 and p21WAF1 Proteins in Lung Cancer and Their Clinical Significance,R734.2
  8. The Effects of RIP on the Immune Function of Renewal Rats Without Colostrums,S853.7
  9. Diagnostic Value of Multiple Tumor Marker Protein Biochip for Patients with Esophageal Carcinoma and Cholangiocarcinoma,R735.1
  10. Study on the Expression and Correlation of Metallothionein and Matrix Metalloproteinase-2 in Non-small Cell Lung Cancer,R734.2
  11. Expression and Their Significance of Apoptosis Regulatory Factors Survivin、XIAP and c-Jun、NF-κB in Epithelial Neoplasm of Ovary,R737.31
  12. Expression and Clinical Significance of Survivin and YAP in Cervical Carcinoma,R737.33
  13. Expression and Clinical Significance of PTEN and Caspase-7 in Gastric Cancer and Precancerous Lesion,R735.2
  14. Combined Detection of Tumor Markers in the Diagnosis and Treatment of Lung Cancer to Determine the Clinical Significance,R734.2
  15. Cloning and Expression Analysis of NCCRP-1 AND IL-10 Genes in Grass Carp (Ctenopharyngodon Idellus),S917.4
  16. Expression and Antibody Preparation of sglt1 from Cyprinus CarpioL.,S917.4
  17. The Effect of Hepatic Denervation on Liver Regeneration after Partially Hepatectomy in Rats,R363
  18. Expression and Correlation of Caspase-3 and Cx43 in Myocardial Infarction with Different Narrow Degree Coronary Artery,R542.22
  19. The Expression and Relationships of Bmi-1 and c-myc in Diffuse Large B-cell Lymphoma Tissues,R733.1
  20. Expression of Caspase-4 and Caspase-3 Gene Related Apoptosis in Pathological Changes of Sternocleidomastoid of Congenital Muscular Torticollis and Four Years Clinical Followed-up for Opereated Patients,R726.8
  21. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9

CLC: > Medicine, health > Oncology > Genitourinary tumors > Female genital tumors > Ovarian tumors
© 2012 www.DissertationTopic.Net  Mobile